Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hiam Chemaitelly and Laith Abu-Raddad.
Hiam Chemaitelly
Connection Strength
8.153
Laith Abu-Raddad
  1. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med. 2021 09; 27(9):1614-1621.
    View in: PubMed
    Score: 0.955
  2. Epidemiology of Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics. J Glob Health. 2019 Dec; 9(2):020408.
    View in: PubMed
    Score: 0.855
  3. Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests. Hepatol Commun. 2019 Mar; 3(3):325-339.
    View in: PubMed
    Score: 0.806
  4. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.243
  5. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Clin Infect Dis. 2021 10 05; 73(7):e1830-e1840.
    View in: PubMed
    Score: 0.243
  6. Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar. JAMA. 2021 07 13; 326(2):185-188.
    View in: PubMed
    Score: 0.239
  7. Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population. Sci Rep. 2021 06 04; 11(1):11837.
    View in: PubMed
    Score: 0.237
  8. SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. iScience. 2021 Jun 25; 24(6):102646.
    View in: PubMed
    Score: 0.237
  9. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021 07 08; 385(2):187-189.
    View in: PubMed
    Score: 0.236
  10. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar. Emerg Infect Dis. 2021 05; 27(5):1343-1352.
    View in: PubMed
    Score: 0.236
  11. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine. 2021 May; 35:100861.
    View in: PubMed
    Score: 0.236
  12. Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses. BMJ Innov. 2021 Apr; 7(2):327-336.
    View in: PubMed
    Score: 0.234
  13. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. Sci Rep. 2021 03 18; 11(1):6233.
    View in: PubMed
    Score: 0.234
  14. Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China. Vaccines (Basel). 2021 Mar 05; 9(3).
    View in: PubMed
    Score: 0.233
  15. Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months. Infect Genet Evol. 2021 03; 88:104684.
    View in: PubMed
    Score: 0.230
  16. Characterizing key attributes of COVID-19 transmission dynamics in China's original outbreak: Model-based estimations. Glob Epidemiol. 2020 Nov; 2:100042.
    View in: PubMed
    Score: 0.228
  17. Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses. Vaccines (Basel). 2020 Nov 09; 8(4).
    View in: PubMed
    Score: 0.228
  18. Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide. PLoS One. 2020; 15(8):e0237959.
    View in: PubMed
    Score: 0.225
  19. Herpes simplex virus type 1 epidemiology in Africa: Systematic review, meta-analyses, and meta-regressions. J Infect. 2019 10; 79(4):289-299.
    View in: PubMed
    Score: 0.209
  20. Does infection with Chlamydia trachomatis induce long-lasting partial immunity? Insights from mathematical modelling. Sex Transm Infect. 2019 03; 95(2):115-121.
    View in: PubMed
    Score: 0.196
  21. Hepatitis C virus infection spontaneous clearance: Has it been underestimated? Int J Infect Dis. 2018 Oct; 75:60-66.
    View in: PubMed
    Score: 0.194
  22. Temporal evolution of HIV sero-discordancy patterns among stable couples in sub-Saharan Africa. PLoS One. 2018; 13(4):e0196613.
    View in: PubMed
    Score: 0.191
  23. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. Ann Epidemiol. 2018 07; 28(7):452-461.
    View in: PubMed
    Score: 0.190
  24. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions. Sci Rep. 2018 01 26; 8(1):1661.
    View in: PubMed
    Score: 0.188
  25. Mapping of new HIV infections in Morocco and impact of select interventions. Int J Infect Dis. 2018 Mar; 68:4-12.
    View in: PubMed
    Score: 0.187
  26. Estimating the annual risk of HIV transmission within HIV sero-discordant couples in sub-Saharan Africa. Int J Infect Dis. 2018 Jan; 66:131-134.
    View in: PubMed
    Score: 0.185
  27. Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions. PLoS One. 2017; 12(10):e0187177.
    View in: PubMed
    Score: 0.185
  28. Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns. J Med Virol. 2018 01; 90(1):131-141.
    View in: PubMed
    Score: 0.183
  29. SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar. Open Forum Infect Dis. 2021 Aug; 8(8):ofab221.
    View in: PubMed
    Score: 0.059
  30. Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions. Res Synth Methods. 2019 Sep; 10(3):476-483.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.